A detailed history of Gray Wealth Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Gray Wealth Management Inc. holds 2,188 shares of ABT stock, worth $222,388. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,188
Previous 2,187 0.05%
Holding current value
$222,388
Previous $240,000 3.33%
% of portfolio
0.11%
Previous 0.12%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$109.52 - $120.96 $109 - $120
1 Added 0.05%
2,188 $248,000
Q4 2023

Jan 31, 2024

BUY
$90.19 - $110.4 $1,082 - $1,324
12 Added 0.55%
2,187 $240,000
Q3 2023

Oct 27, 2023

BUY
$95.53 - $114.62 $11,559 - $13,869
121 Added 5.89%
2,175 $210,000
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $100 - $112
1 Added 0.05%
2,054 $223,000
Q1 2023

Apr 11, 2023

BUY
$96.86 - $114.01 $96 - $114
1 Added 0.05%
2,053 $207,000
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $3,232 - $3,791
-34 Reduced 1.63%
2,052 $225,000
Q3 2022

Jan 03, 2023

SELL
$96.76 - $112.03 $2,031 - $2,352
-21 Reduced 1.0%
2,086 $202,000
Q2 2022

Jan 03, 2023

BUY
$102.07 - $123.37 $204 - $246
2 Added 0.1%
2,107 $229,000
Q1 2022

Jan 03, 2023

BUY
$114.02 - $139.04 $114 - $139
1 Added 0.05%
2,105 $249,000
Q3 2021

Jan 03, 2023

BUY
$116.66 - $129.06 $233 - $258
2 Added 0.1%
2,104 $249,000
Q2 2021

Jan 03, 2023

BUY
$105.79 - $124.53 $3,702 - $4,358
35 Added 1.69%
2,102 $244,000
Q1 2021

Jan 03, 2023

BUY
$108.84 - $128.23 $224,972 - $265,051
2,067 New
2,067 $248,000
Q4 2020

Jan 13, 2023

BUY
$105.0 - $114.42 $2,205 - $2,402
21 Added 1.03%
2,066 $225,000
Q3 2020

Jan 13, 2023

SELL
$91.64 - $111.29 $3,757 - $4,562
-41 Reduced 1.97%
2,045 $222,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $178B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gray Wealth Management Inc. Portfolio

Follow Gray Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gray Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gray Wealth Management Inc. with notifications on news.